Medication info

Rosuvastatin Calcium (unmodified) 20 mg Dispersible Tablets

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›20.8mg / 1 tablet
Manufacturer / importer
BC World Healthcare Co., Ltd.
Appearance
White to pale yellow circular orally disintegrating tablets
Packaging
28 tablets/box [14 tablets/PTP × 2]
Approval status
Active

MFDS item code 202107840 · Approved 2021.12.07

Summary

Main use
Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces the risk of cardiovascular disease
Who takes it
Adults · Children
Adult dose
This medicine is an orally disintegrating tablet. Place it on the tongue, allow it to dissolve, and take it without water. 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg once daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
BC World Healthcare Co., Ltd.

Efficacy & effects

Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces the risk of cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • coronary heart disease risk factors
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used in patients with primary hypercholesterolemia and heterozygous familial hypercholesterolemia, and mixed hyperlipidemia when not controlled by diet and exercise alone. Additionally, it is used as an adjunct in patients with homozygous familial hypercholesterolemia when combined with diet or other lipid-lowering therapies. It helps lower total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis, and is effective in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It can also be used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia and assists in reducing the risks of stroke, myocardial infarction, and arterial revascularization in adult patients at high risk for cardiovascular disease. In summary, this medication is used to effectively manage high cholesterol and reduce the risk of cardiovascular disease.

How to take

Adult dose

This medicine is an orally disintegrating tablet. Place it on the tongue, allow it to dissolve, and take it without water. 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg once daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, it should not be given to patients who are allergic to it, those with severely impaired liver function, patients with myopathy, those taking certain immunosuppressants, severely impaired renal function patients, and women who are pregnant or breastfeeding. It should be used with caution in individuals with diminished liver function or those consuming large amounts of alcohol. Liver function tests should be conducted several times before and during treatment; if the patient has hypothyroidism or nephrotic syndrome, these conditions should be treated before starting this medication. Muscle-related side effects such as myalgia, muscle weakness, and in severe cases, rhabdomyolysis have been reported, thus if any symptoms of muscle pain or weakness occur, the patient should notify the doctor immediately and undergo evaluation. Patients at higher risk of muscle damage should be particularly vigilant and may need to discontinue the medication as necessary. This medication may affect the kidneys when taken at high doses, so it is advisable to perform regular kidney function tests. Asian patients may display higher blood concentrations of this medication, potentially necessitating dose adjustments. This medication is also used in children and adolescents, but while major impacts on growth and sexual characteristics were not observed after 1 year of observation, the safety of long-term use has not been fully established. During treatment, side effects such as rare headaches, dizziness, constipation, nausea, abdominal pain, skin rash, pruritus, myalgia, asthenia, hematuria, cough, diarrhea, arthralgia, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, depression, sleep disorders (including insomnia and nightmares), sexual dysfunction, gynecomastia, memory impairment, amnesia, memory loss, memory disturbances, and confusion may occasionally occur. This medication may affect liver function, so if symptoms of liver damage (for example, jaundice, severe fatigue) occur, the patient should discontinue use immediately and consult a physician. It may interact with other medications; hence, patients must inform their doctor or pharmacist of any other medications they are taking, particularly those from specific antiviral agents, immunosuppressants, antifungals, antibiotics, or fibrate drug classes. Women who are pregnant or may become pregnant should be cautious as this medication may pose risks to the fetus, thus appropriate contraception should be utilized, and if planning a pregnancy or if pregnancy is confirmed, treatment should be discontinued immediately. In case of overdose, there is no specific antidote, so one should seek immediate medical attention and undergo tests for liver function and muscle damage. This medication does not significantly impair the ability to drive or operate machinery, but due to the possibility of dizziness, caution is advised.

Side effects

  • Allergic reactions including angioedema
  • diabetes
  • headache
  • dizziness
  • constipation
  • nausea
  • abdominal pain
  • pancreatitis
  • itching
  • rash
Show 48 more
  • hives
  • myalgia
  • myopathy
  • rhabdomyolysis
  • weakness
  • polyneuropathy
  • amnesia
  • peripheral neuropathy
  • myasthenia gravis
  • cough
  • shortness of breath
  • diarrhea
  • oculobulbar weakness
  • thrombocytopenia
  • jaundice
  • hepatitis
  • increased transaminases
  • Stevens-Johnson syndrome
  • drug-induced urticaria
  • lupus-like syndrome
  • muscle rupture
  • arthralgia
  • immune-mediated necrotizing myopathy
  • hematuria
  • edema
  • depression
  • sleep disorders
  • interstitial lung disease
  • sexual dysfunction
  • gynecomastia
  • fatal and non-fatal liver failure
  • cognitive impairment
  • increased ALT
  • chest pain
  • muscle cramps
  • gout
  • erectile dysfunction
  • increased AST
  • joint pain
  • fatigue
  • numbness
  • paresthesia
  • chest discomfort
  • decreased appetite
  • abdominal distension
  • abnormal liver function tests
  • syncope
  • body aches

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Furthermore, it is best kept in a cool place, specifically at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White to pale yellow circular orally disintegrating tablets

Package unit

28 tablets/box [14 tablets/PTP × 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.